Marshall Wace North America’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-175,190
Closed -$11.6M 1756
2021
Q1
$11.6M Sell
175,190
-90,088
-34% -$5.6M 0.05% 367
2020
Q4
$16.9M Buy
+265,278
New +$17.1M 0.08% 283
2020
Q3
Sell
-44,570
Closed -$2.61M 1455
2020
Q2
$2.61M Buy
+44,570
New +$2.74M 0.02% 512
2019
Q4
Sell
-3,574
Closed -$264K 1577
2019
Q3
$264K Buy
+3,574
New +$250K ﹤0.01% 912
2019
Q2
Sell
-11,332
Closed -$713K 1579
2019
Q1
$713K Sell
11,332
-13,562
-54% -$799K 0.01% 733
2018
Q4
$1.35M Buy
+24,894
New +$1.42M 0.01% 539
2018
Q3
Sell
-10,400
Closed -$604K 1340
2018
Q2
$604K Buy
+10,400
New +$569K ﹤0.01% 1043

Other funds holding SRE

Marshall Wace North America's SRE Position: Q2 2021 in Review

Marshall Wace North America sold out of Sempra (SRE) in Q2 2021, closing a stake of 175,190 shares — an estimated $11.6M sold.

Marshall Wace North America first reported a position in SRE in Q2 2018 and held it in 7 quarters. The position peaked at $16.9M in Q4 2020. 816 funds tracked by Wall St. Rank hold SRE as of Q2 2021.

  • Marshall Wace North America reported no remaining Sempra position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 175,190 Sempra shares in Q2 2021, an estimated $11.6M.
  • Marshall Wace North America first reported a position in Sempra in Q2 2018 and held it in 7 quarters.
  • Marshall Wace North America's Sempra position peaked at $16.9M in Q4 2020.
  • 816 funds tracked by Wall St. Rank held Sempra as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.